L
Laurie Myers
Researcher at Duke University
Publications - 17
Citations - 2947
Laurie Myers is an academic researcher from Duke University. The author has contributed to research in topics: Efavirenz & Hematopoietic stem cell transplantation. The author has an hindex of 14, co-authored 17 publications receiving 2836 citations.
Papers
More filters
Journal ArticleDOI
Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Rebecca H. Buckley,Sherrie E. Schiff,Richard I. Schiff,M. Louise Markert,Larry W. Williams,Joseph L. Roberts,Laurie Myers,Frances E. Ward +7 more
TL;DR: Transplantation of marrow from a related donor is a life-saving and life-sustaining treatment for patients with any type of severe combined immunodeficiency, even when there is no HLA-identical donor.
Journal ArticleDOI
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
Grace A. McComsey,Douglas Kitch,Eric S. Daar,Camlin Tierney,Nasreen C. Jahed,Pablo Tebas,Laurie Myers,Kathleen Melbourne,Belinda Ha,Paul E. Sax,Paul E. Sax +10 more
TL;DR: Compared with ABC-3TC, TDF-FTC-treated participants had significantly greater decreases in spine and hip BMD, whereas ATV/r led to more significant losses in spine, but not hip, BMD than EFV.
Journal ArticleDOI
Genetic Linkage of Hyper-IgE Syndrome to Chromosome 4
Bodo Grimbacher,Alejandro A. Schäffer,Steven M. Holland,Joie Davis,John I. Gallin,Harry L. Malech,T. Prescott Atkinson,Bernd H. Belohradsky,Rebecca H. Buckley,Fausto Cossu,Teresa Espanol,Ben Zion Garty,Núria Matamoros,Laurie Myers,Robert P. Nelson,Hans D. Ochs,E.D. Renner,Nele Wellinghausen,Jennifer M. Puck +18 more
TL;DR: Multipoint analysis and simulation testing confirmed that the proximal 4q region contains a disease locus for hyper-IgE syndrome.
Journal ArticleDOI
Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival
TL;DR: An improved outcome for this otherwise fatal syndrome could be achieved with newborn screening for lymphopenia so that transplantation could be performed under favorable thymopoietic conditions.
Journal ArticleDOI
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
Paul E. Sax,Camlin Tierney,Ann C. Collier,Margaret A. Fischl,Katie R. Mollan,Lynne Peeples,Catherine Godfrey,Nasreen C. Jahed,Laurie Myers,David Katzenstein,Awny Farajallah,James F. Rooney,Belinda Ha,William C. Woodward,Susan L. Koletar,Victoria A. Johnson,P. Jan Geiseler,Eric S. Daar +17 more
TL;DR: In patients with screening HIV-1 RNA levels of 100,000 copies per milliliter or more, the times to virologic failure and the first adverse event were both significantly shorter in patients randomly assigned to abacavir-lamivudine than in those assigned to tenofovir DF-emtricitabine.